Key Finding
Moxibustion reduces arthritis inflammation by promoting M2 macrophage polarization through SIRT5-mediated desuccinylation of GLUD1, which inverts the succinate/α-KG ratio.
Researchers investigated how moxibustion, a traditional Chinese medicine treatment involving burning herbs near the skin, reduces inflammation in arthritis. Using mice with artificially induced arthritis, scientists discovered that moxibustion works by changing how immune cells called macrophages behave in the body. Macrophages come in two main types: M1 macrophages that promote inflammation and M2 macrophages that reduce it. The study found that moxibustion helps shift the balance from inflammatory M1 macrophages to anti-inflammatory M2 macrophages. This happens through a complex process involving a protein called SIRT5, which modifies another enzyme (GLUD1) that controls the production of specific molecules in cells. When moxibustion was applied, it changed the levels of two important substances: succinate (which decreased) and alpha-ketoglutarate (which increased). This chemical shift encouraged more M2 macrophages to form, reducing inflammation and swelling in arthritic paws. The researchers also tested a drug that mimics moxibustion's effects on SIRT5, and it produced similar anti-inflammatory results. For patients with arthritis or other inflammatory conditions, this research helps explain the biological mechanisms behind why moxibustion may provide relief. The study suggests moxibustion doesn't just provide temporary comfort but actually influences immune cell behavior at a molecular level. If you're considering moxibustion for inflammatory conditions, seek treatment from a qualified, licensed acupuncturist trained in traditional Chinese medicine techniques.
This study investigated SIRT5-mediated mechanisms underlying moxibustion's anti-inflammatory effects in Complete Freund's Adjuvant (CFA)-induced arthritis using C57BL/6J and Sirt5 knockout mice. Researchers employed moxibustion treatment and acupoint injections of MC3482 (SIRT5 desuccinylation inhibitor), analyzing outcomes via paw capacity assays, ELISA, flow cytometry, immunofluorescence, and LC-MS/MS proteomics. Results demonstrated that moxibustion significantly increased M2 macrophage polarization while decreasing M1 macrophages. The mechanism involves SIRT5-mediated desuccinylation of GLUD1, which inverted the succinate/α-KG ratio (decreasing succinate, increasing α-KG). This metabolic shift promoted anti-inflammatory M2 macrophage differentiation and reduced inflammation markers. MC3482 injections replicated moxibustion's effects, confirming SIRT5's role in the therapeutic mechanism. Clinical takeaway: Moxibustion's anti-inflammatory effects in arthritis operate through specific post-translational modifications affecting macrophage polarization, providing mechanistic support for its use in inflammatory conditions and suggesting potential for targeted therapeutic approaches combining traditional and molecular interventions.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Different moxibustion temperatures activate distinct thermosensitive proteins and pathways that influence the phenotypic remodeling of primary lesion cells in rheumatoid arthritis, including fibroblast-like synoviocytes, macrophages, and T cells.
📌 Moxibustion significantly reduced arthritis severity in animal models with large effect sizes (SMD -3.72 for arthritis index) while suppressing pro-inflammatory cytokines and key signaling pathways including NF-κB and NLRP3 inflammasome.
📌 Three transdermal moxibustion compounds—Citral, α-Terpineol, and Borneol—were identified as targeting TNF-α to reduce rheumatoid arthritis through MAPK pathway inhibition and MMP modulation.